David Cachia

Neuro oncologist at the University of Massachusetts

[David Cachia @Dave_C09]

Final results of the CATNON trial confirm that adjuvant TMZ makes a difference in WHO Grade 3 IDHmt astrocytomas https://t.co/PQ4N9VxRBF

[David Cachia @Dave_C09]

Fascinating updates on neuron-glioma interactions

[Michelle Monje 🟦 @michelle_monje]

Preprint alert: Serotonergic neuron-glioma interactions drive high-grade glioma pathophysiology | bioRxiv https://t.co/3c73B2AdhG

[Ashley Love Sumrall, MD, FACP, FASCO @AshleySumrallMD]

Looks like a great session! #btsm

[David Cachia @Dave_C09]

@ProfAJChalmers @DrFlorienBoele Well deserved

[David Cachia @Dave_C09]

Very promising study using intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas | Nature https://t.co/6xswW72uMW

[David Cachia @Dave_C09]

I agree. Important to highlight basic science work that led to this approval

[Roel Verhaak @roelverhaak]

As we celebrate the approval of vorasidenib for treatment of grade II IDH-mutant, I would like to recognize those that developed the original compounds. See https://t.co/38HCJgegUc, https://t.co/Clj7dXFGZW and perhaps most importantly https://t.co/AfN36y1TZP. Fantastic job!

[David Cachia @Dave_C09]

Vorasidenib FDA approved for treating IDHmt low grade gliomas https://t.co/wsU3oHSHng

[David Cachia @Dave_C09]

#GBMDay We need better treatment options for our patients

[David Cachia @Dave_C09]

Another needed treatment option for NF2 patients

[NEJM @NEJM]

Brigatinib produced responses in 23% of all tumors in patients with NF2-related tumors (schwannomas, meningiomas, and ependymomas), with hearing improvement in approximately one third of patients. Read the full INTUITT-NF2 trial results: https://t.co/k7tOruFhAn

[David Cachia @Dave_C09]

@antgiorda Ferrari?😂

[David Cachia @Dave_C09]

Very interesting work

[Cancer Cell @Cancer_Cell]

Online Now: Neural deception: Breast cancer co-opts neuronal mechanisms to evade the immune system https://t.co/Fxalp5rv1q

[David Cachia @Dave_C09]

@MayoClinic @MayoClinicNeuro @gelarehzadeh Congratulations!

[David Cachia @Dave_C09]

@DrWasilewski @AllinaHealth Congratulations!

[David Cachia @Dave_C09]

@NIHBrainTumor @MRGneuroonc @NCIResearchCtr A pioneer and leader in the field who i had the honor of calling a mentor and colleague. Will be missed

[David Cachia @Dave_C09]

@DrAnthonyIzzo @AANmember Congratulations! 🎉

[David Cachia @Dave_C09]

Very well written review https://t.co/qcIRgSk29l

[Joe Costello @josephcostell14]

We are excited to share our new publication! It is a multi-year, multidisciplinary basic science and clinical team effort. Thank you Dept of Neurosurgery and UCSF Brain Tumor Center for making this possible!
Radhika Mathur et al, Cell, Jan 18, 2024
https://t.co/GpMCziYjaW

[David Cachia @Dave_C09]

Important work to address a pressing issue in the field https://t.co/2QYeSBvf1d

[David Cachia @Dave_C09]

Great to catch up with colleagues at #SNO2023

[David Cachia @Dave_C09]

@AshleySumrallMD @NeuroOnc Thanks for your support